IEX - Forummoderator schreef op 28 januari 2017 09:11:
Euronext:
Company Profile:
Probiodrug specializes in the research and development of therapeutic products for the treatment of Alzheimer disease.At the end of 2015, the group has a portfolio of 2 products in preclinical development phase (PBD-C06 and PQ1565) and a product in phase I of clinical development (PQ912).
Groet Henk